Grove Bank & Trust’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$596 Sell
44
-5
-10% -$60 ﹤0.01% 853
2026
Q1
$294 Sell
49
-65
-57% -$489 ﹤0.01% 840
2025
Q4
$817 Sell
114
-80
-41% -$632 ﹤0.01% 828
2025
Q3
$2.07K Sell
194
-300
-61% -$2.94K ﹤0.01% 780
2025
Q2
$4.78K Hold
494
﹤0.01% 701
2025
Q1
$7.36K Hold
494
﹤0.01% 621
2024
Q4
$7.37K Hold
494
﹤0.01% 556
2024
Q3
$9.45K Hold
494
﹤0.01% 502
2024
Q2
$10.2K Hold
494
﹤0.01% 475
2024
Q1
$9.29K Sell
494
-5
-1% -$86 ﹤0.01% 507
2023
Q4
$7.2K Sell
499
-242
-33% -$3.29K ﹤0.01% 511
2023
Q3
$12.9K Sell
741
-124
-14% -$2.59K ﹤0.01% 494
2023
Q2
$18K Sell
865
-196
-18% -$4.26K ﹤0.01% 457
2023
Q1
$25K Sell
1,061
-46
-4% -$1.24K 0.01% 443
2022
Q4
$31K Buy
+1,107
New +$28.3K 0.01% 425

Other funds holding OGN

Grove Bank & Trust's OGN Position: Q2 2026 in Review

Grove Bank & Trust reduced its Organon & Co (OGN) stake by 10% in Q2 2026, selling an estimated $60 and leaving 44 shares worth $596. The position accounts for ﹤0.01% of the portfolio, ranked #853.

Grove Bank & Trust first reported a position in OGN in Q4 2022 and has held it in 15 quarters since. The position peaked at $31K in Q4 2022. 107 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Grove Bank & Trust held 44 shares of Organon & Co worth $596 as of Q2 2026.
  • Grove Bank & Trust sold 5 Organon & Co shares in Q2 2026, an estimated $60.
  • Organon & Co made up ﹤0.01% of Grove Bank & Trust's portfolio in Q2 2026, its #853 holding.
  • Grove Bank & Trust first reported a position in Organon & Co in Q4 2022 and has held it in 15 quarters since.
  • Grove Bank & Trust's Organon & Co position peaked at $31K in Q4 2022.
  • 107 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Grove Bank & Trust's 13F filing for Q2 2026, filed 7 Jul 2026.